Scientists pinpoint new vaccine adjuvant that promotes potent anti-tumor immunity
Scientists from Trinity College Dublin have made an important breakthrough that offers promise for developing new immune therapies for cancer. They have discovered that a vaccine adjuvant called C100 promotes potent anti-tumor ...
May 9, 2024
0
19
GPS-like system shows promise as HIV vaccine strategy to elicit critical antibodies
A team led by the Duke Human Vaccine Institute (DHVI) has developed a vaccine approach that works like a GPS, guiding the immune system through the specific steps to make broadly neutralizing antibodies against HIV.
May 9, 2024
0
12
AstraZeneca's COVID vaccine withdrawn—it was a victim of misinformation right to the end, researcher says
The Oxford-AstraZeneca vaccine was a critical part of the COVID-19 pandemic response. However, on May 7, 2024, the European Commission announced the vaccine is no longer authorized for use.
May 9, 2024
0
14
Hospitals no longer must report COVID data to CDC, spotlighting clunky system
As COVID-19 swept over Phoebe Putney Health System and Southwest Georgia in the first days of the pandemic, residents and public health officials were desperate to know what patients had and how far it was spreading. The ...
May 9, 2024
0
0
A third COVID vaccine dose improves defense for some clinically extremely vulnerable patients
A major clinical trial has found that an additional COVID-19 vaccine dose led to the majority of clinically extremely vulnerable people mounting defensive antibodies against COVID-19.
May 8, 2024
0
86
Tailored vaccine could one day treat eczema in children
New research from a multi-disciplinary team at Trinity College Dublin suggests a "tailored vaccine" might hold the key to treating bacteria-driven flares of eczema in children. The work has been published in JCI Insight.
May 8, 2024
0
1
There's a new set of COVID variants called FLiRT: what you need to know
The virus behind COVID has mutated again, this time producing variants nicknamed FLiRT, the U.S. Centers for Disease Control and Prevention (CDC) has reported.
May 8, 2024
0
20
AstraZeneca withdraws Covid vaccine as demand dives
Anglo-Swedish drugmaker AstraZeneca on Wednesday said it was withdrawing COVID vaccine Vaxzevria, one of the first produced in the deadly pandemic, citing "commercial reasons" following a slump in demand.
May 8, 2024
0
0
COVID-19 study examines link between insurance, race and vaccination trends
Research from recent graduate Brock Santi of the University of Hawaiʻi at Manoa John A. Burns School of Medicine (JABSOM) explored the link between COVID-19, insurance coverage, race, ethnicity and vaccination, shedding ...
May 8, 2024
0
0
Biomaterial vaccine enhances lymph node expansion following vaccination, boosting anti-tumor immunity
Each one of us has around 600 lymph nodes (LNs)—small, bean-shaped organs that house various types of blood cells and filter lymph fluid—scattered throughout our bodies. Many of us have also experienced some of our LNs ...
May 6, 2024
0
49
Personalized mRNA vaccines: A new approach in melanoma treatment
A personalized mRNA vaccine to treat melanoma has now reached late-stage trials in the UK. This is just the latest step in improving the cure rate of cancer.
May 4, 2024
0
0
Study reveals how COVID-19 vaccines prevent severe disease
A study by scientists at the University of Oxford, has unveiled crucial insights into the way that COVID-19 vaccines mitigate severe illness in those who have been vaccinated.
May 3, 2024
0
56
Rotavirus vaccinations in NICU pose minimal risk, finds study
Rotavirus vaccines do not cause significant outbreaks of the disease in neonatal intensive care units (NICUs), according to a new national study. The research will be presented at the Pediatric Academic Societies (PAS) 2024 ...
May 3, 2024
0
1
Controlled human infection study paves the way to improving vaccines and therapeutics development
A first-of-its-kind study led by the University of Oxford has successfully investigated human immunity against COVID-19 in people who already have antibodies against it. The results suggest that previous infection, together ...
May 2, 2024
0
16
Experimental vaccine targets portions of the flu virus that don't change
Duke researchers have opened a new avenue in the attack against influenza viruses by creating a vaccine that encourages the immune system to target a portion of the virus surface that is less variable.
May 1, 2024
0
11
Q&A: AstraZeneca's COVID-19 vaccine and blood clots—what you need to know
Pharmaceutical giant AstraZeneca admitted in court this week that its COVID-19 vaccine can cause a rare but deadly blood-clotting condition that has become the central focus of a class-action lawsuit worth potentially $125 ...
May 1, 2024
0
4
Study identifies immunity threshold for protection against COVID-19 in children
As COVID-19 becomes endemic, an important group of people who continue to require vaccination is future birth cohorts of children. Yet, in the face of everchanging variants, as well as the waning of antibodies with time after ...
Apr 30, 2024
0
7
EU drug watchdog urges COVID-19 vaccine update
The EU's drug watchdog urged Tuesday that anti-COVID jabs be updated before another round of vaccinations to counter a new variant of the virus, which is still claiming thousands of lives.
Apr 30, 2024
0
4